Home » Stocks » Eton Pharmaceuticals

Eton Pharmaceuticals, Inc. (ETON)

Stock Price: $5.16 USD -0.05 (-0.96%)
Updated Jul 9, 2020 2:31 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 107.93M
Revenue (ttm) 558,000
Net Income (ttm) -19.96M
Shares Out 20.92M
EPS (ttm) -1.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 9, 2020
Last Price $5.16
Previous Close $5.21
Change ($) -0.05
Change (%) -0.96%
Day's Open 5.27
Day's Range 5.01 - 5.39
Day's Volume 139,534
52-Week Range 2.50 - 9.07

More Stats

Market Cap 107.93M
Enterprise Value 100.17M
Earnings Date (est) Aug 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 20.92M
Float 10.56M
EPS (basic) -1.11
EPS (diluted) -1.11
FCF / Share -1.06
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 280,788
Short Ratio 3.18
Short % of Float 2.37%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 193.43
PB Ratio 10.68
Revenue 558,000
Operating Income -19.93M
Net Income -19.96M
Free Cash Flow -19.19M
Net Cash 7.77M
Net Cash / Share 0.37
Gross Margin 90.68%
Operating Margin -3,571.33%
Profit Margin -3,576.90%
FCF Margin -3,438.71%
ROA -61.88%
ROE -133.68%
ROIC -488.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$14.33*
(177.71% upside)
Low
10.0
Current: 5.16
High
18.0
Target: 14.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018
Revenue0.96-
Gross Profit0.51-
Operating Income-18.60-10.32
Net Income-18.32-12.74
Shares Outstanding17.766.42
Earnings Per Share-1.03-5.80
Operating Cash Flow-18.03-8.15
Capital Expenditures-1.10-0.24
Free Cash Flow-19.12-8.38
Cash & Equivalents12.0726.74
Total Debt4.56-
Net Cash / Debt7.5126.74
Assets17.0728.33
Liabilities6.522.02
Book Value10.5526.30
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Eton Pharmaceuticals, Inc.
Country United States
Employees 17
CEO Sean E. Brynjelsen

Stock Information

Ticker Symbol ETON
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ETON
IPO Date November 13, 2018

Description

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products. The company offers Biorphen, a phenylephrine hydrochloride injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. It also develops EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-203, which is injectable product candidates for use in the hospital setting; ET-103, an oral liquid product candidate for hypothyroidism; ET-101 and ET-104, which are oral liquid product candidates for neurological indications; DS-300 and DS-100, which are injectable product candidates; and ET-105, a lamotrigine for oral suspension. Eton Pharmaceuticals, Inc. was founded in 2017 and is based in Deer Park, Illinois.